Incorporating Genomic Information in the Treatment of MDS
Offered By: Cancer Genomics Consortium via YouTube
Course Description
Overview
Explore the latest advancements in incorporating genomic information for treating Myelodysplastic Syndrome (MDS) through this keynote presentation from the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Delivered by Guillermo Garcia-Manero and introduced by Rashmi Kanagal-Shamanna, this hour-long talk delves into cutting-edge approaches for leveraging genomic data to improve MDS patient care. Gain insights into how clinical cytogeneticists, molecular geneticists, and molecular pathologists are working together to enhance cancer diagnosis and treatment strategies. Learn about the CGC's mission to promote best practices in clinical cancer genomics and their goal of ensuring accurate genomic-based diagnoses for all cancer patients to guide optimal therapy selection.
Syllabus
Keynote Presentation - Incorporating genomic information in the treatment of MDS
Taught by
Cancer Genomics Consortium
Related Courses
Fostering Change: ACMG's New Diversity, Equity and Inclusion CommitteeAmbry Genetics via YouTube Somatic Mutations and Their Contribution to Bone Marrow Failure and Inflammation
Cancer Genomics Consortium via YouTube TP53 Alterations in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Cancer Genomics Consortium via YouTube ISCN 2024 Update: Preview of New Genomic Mapping Nomenclature
Cancer Genomics Consortium via YouTube Cytogenetics in the Era of Genomics - Invited Speaker Presentation
Cancer Genomics Consortium via YouTube